ASPIRIN FOR THE PRIMARY PROPHYLAXIS OF COLORECTAL CANCER

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

B. LANKARANI KAMRAN

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Colorectal Research Year:2013 | Volume:1 | Issue:3 Page(s): 77-80

Download Full-Text

View:

191

Download:

Cites:

Information Journal Paper

Title

ASPIRIN FOR THE PRIMARY PROPHYLAXIS OF COLORECTAL CANCER

Author(s)

B. LANKARANI KAMRAN | Issue Writer Certificate

Keywords

ASPIRIN

COLORECTAL CANCER

PRIMARY PREVENTION

Abstract

Context: Increasing epidemic of COLORECTAL CANCER worldwide and the expenses of the current screening and treatment of this potentially fatal condition have raised the interest of in finding a primary prophylactic measure. ASPIRIN has been administrated for more than 40 years to achieve this.Evidence Acquisitions: In this manuscript, we reviewed the best available evidence on the prophylatic use of ASPIRIN for COLORECTAL CANCER prevention.Results: The analysis and large cohort studies revealed that although using ASA would probably decrease the risk of colon cancer, this would not occur before 5-8 years after treatment. ASA usage would increase the risk of major gastrointestinal bleeding.Conclusions: ASPIRIN has been proposed as a chemopreventive agent in COLORECTAL CANCER (CRC) for many years, but there are still debates on the proper candidates, treatment time and cost benefit analysis of this potentially harmful drug. This brief review would try to answer these questions using the currently available evidence.

Cites

No record.

References

No record.

Cite

APA: Copy

B. LANKARANI, KAMRAN. (2013). ASPIRIN FOR THE PRIMARY PROPHYLAXIS OF COLORECTAL CANCER. IRANIAN JOURNAL OF COLORECTAL RESEARCH (ANNALS OF COLORECTAL RESEARCH), 1(3), 77-80. SID. https://sid.ir/paper/334945/en

Vancouver: Copy

B. LANKARANI KAMRAN. ASPIRIN FOR THE PRIMARY PROPHYLAXIS OF COLORECTAL CANCER. IRANIAN JOURNAL OF COLORECTAL RESEARCH (ANNALS OF COLORECTAL RESEARCH)[Internet]. 2013;1(3):77-80. Available from: https://sid.ir/paper/334945/en

IEEE: Copy

KAMRAN B. LANKARANI, “ASPIRIN FOR THE PRIMARY PROPHYLAXIS OF COLORECTAL CANCER,” IRANIAN JOURNAL OF COLORECTAL RESEARCH (ANNALS OF COLORECTAL RESEARCH), vol. 1, no. 3, pp. 77–80, 2013, [Online]. Available: https://sid.ir/paper/334945/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops